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Structural insights into tetraspanin CD9 function
Rie Umeda1,10, Yuhkoh Satouh2,3,10, Mizuki Takemoto 1,9, Yoshiko Nakada-Nakura 4, Kehong Liu4,
Takeshi Yokoyama5, Mikako Shirouzu 5, So Iwata 4,6, Norimichi Nomura 4, Ken Sato 2,7,
Masahito Ikawa 3, Tomohiro Nishizawa 1,8✉ & Osamu Nureki 1✉
Tetraspanins play critical roles in various physiological processes, ranging from cell adhesion
to virus infection. The members of the tetraspanin family have four membrane-spanning
domains and short and large extracellular loops, and associate with a broad range of other
functional proteins to exert cellular functions. Here we report the crystal structure of CD9
and the cryo-electron microscopic structure of CD9 in complex with its single membrane-
spanning partner protein, EWI-2. The reversed cone-like molecular shape of CD9 generates
membrane curvature in the crystalline lipid layers, which explains the CD9 localization in
regions with high membrane curvature and its implications in membrane remodeling. The
molecular interaction between CD9 and EWI-2 is mainly mediated through the small residues
in the transmembrane region and protein/lipid interactions, whereas the fertilization assay
revealed the critical involvement of the LEL region in the sperm-egg fusion, indicating the
different dependency of each binding domain for other partner proteins.
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The tetraspanin protein family members are ubiquitouslyexpressed in higher organisms and involved in a widerange of physiological processes, such as cell motility and
adhesion, tumor invasion, fertilization, and virus infection1–4.
Despite their broad involvement in physiological processes, the
knock-out of the tetraspanin gene results in only moderate phe-
notypes, indicating their functional redundancy, except for some
tissue-specific subtypes, such as peripherins in the retina5 and
uroplakins in the bladder6. The importance of tetraspanins was
highlighted by the infertile phenotype of the Cd9 KO female
mice7–9, but its molecular function; specifically how CD9 is
involved in sperm-egg binding/fusion, has remained poorly
understood. Based on biochemical studies, tetraspanins are pro-
posed to form complex protein networks in biological mem-
branes, by recruiting other partner proteins into the tetraspanin-
enriched microdomain (TEM). Therefore, tetraspanin is con-
sidered as a molecular organizer that associates with the partner
proteins to exert their cellular functions. However, a recent study
has challenged the classical view of the tetraspanin network,
showing that each tetraspanin cluster consists of only a small
number of molecules and only partially overlaps with the loca-
lization of its binding partner, MHC-II, in B-cells10. Therefore,
further studies will be required to elucidate their physiological
functions.
The tetraspanin proteins share the same membrane topology of
four membrane-spanning domains and the first and second
extracellular loops, termed the short extracellular loop (SEL) and
large extracellular loop (LEL), respectively (Supplementary
Fig. 1). The recently reported crystal structure of a tetraspanin
protein, CD81, revealed a reversed teepee-like arrangement of the
four transmembrane (TM) helices, which create a central pocket
in the intramembranous region11. The molecular dynamics (MD)
simulation, together with the mutation analysis, suggested that
cholesterol binding at the central cavity modulates CD81 asso-
ciation with its partner protein, CD1911. However, the means by
which tetraspanins form complex protein networks in cell
membranes remain poorly understood. While the LEL is impli-
cated in molecular associations with partner proteins, the detailed
interactions are still unclear, and thus the associations of tetra-
spanins with broad members of single membrane-spanning
proteins, including integrins, immunoglobulin superfamily pro-
teins, and TGF-β receptors, and how tetraspanins regulate their
functions are not well understood. Here, we report the crystal
structure of CD9 and the cryo-electron microscopy (cryo-EM)
structure of CD9 in complex with its partner protein, EWI-2.
Combined with the mutational analysis of CD9 in mouse egg
fertilization, we show that the broad interactions through TM3
and the LEL are important for the molecular associations of
tetraspanins, which are critical for their functions.
Results
Crystal structure of human CD9. We first crystallized wild-type
human CD9 by the lipidic cubic phase (LCP) method, but the
obtained crystals diffracted to about only 20 Å. Considering the
possibility that the molecular flexibility of CD9 hinders the tight
crystal packing interactions, we made several series of truncated
constructs, and the construct that lacked part of the LEL region
(Thr175-Lys179) and the C-terminal tail (Glu226-Val228) yielded
good quality crystals, which diffracted to over 3.0 Å12. For the
experimental phase determination, we introduced an additional
cysteine residue at Ile20 and co-crystallized the protein with
methyl-mercury (I) chloride. The structure was determined by
the single isomorphous replacement with anomalous scattering
(SIRAS) method and refined to 2.7 Å resolution (Supplementary
Table 1).
Human CD9 is folded into four-transmembrane helices, with
their intracellular ends tightly bundled together and their
extracellular ends loosely packed with each other, creating a
large central cavity inside the intramembranous region
(Fig. 1a–c). The short extracellular loop (SEL) between TM1
and TM2 and the large extracellular loop (LEL) between TM3 and
TM4 extend over this central cavity. The LEL is stabilized by
disulfide bond pairs between the highly conserved cysteine
residues (Cys152-Cys181 and Cys153-Cys167) (Fig. 1a). We
observed extra densities near the cysteine residues on the
intracellular ends of the TM helices (Cys9, Cys79, Cys87, and
Cys219), which are probably derived from the attached palmitoyl
moieties, consistent with the heterogeneous bands of the purified
CD9 protein observed in the SDS-PAGE analysis12. These lipid
modifications probably anchor the TM helices on the lipid
membrane and stabilize the TM bundle at the intracellular end.
CD9 shares high sequence similarity (approximately 60%) with
the related tetraspanin protein CD81, and accordingly, the overall
structure of CD9 is essentially similar to the previously reported
structure of CD8111 (Supplementary Fig. 2). Nonetheless, the
current high-resolution CD9 structure allowed the modeling of
the entire molecule, including the SEL, which were not modeled
in the previous CD81 structure due to the high anisotropy of the
crystal. While the extracellular loops (SEL and LEL) have
diverged sequences, the transmembrane region is highly con-
served among the tetraspanin family members (Supplementary
Fig. 1). Therefore, this arrangement of the four transmembrane
helices in the CD9 and CD81 structures might represent the
common architecture of the tetraspanin family proteins.
The current LCP crystal of CD9 revealed a unique feature: due
to the cone-like molecular shape, the arrayed molecules in the
lipidic environment generate curvature in the lipid membranes,
resulting in wavy layers in the crystalline lattice (Fig. 1d). Several
studies have shown the localization of tetraspanin proteins in
specific regions of curved cell membranes. For instance, CD9 and
its related tetraspanin, CD81, are localized in the growing tips of
virus buds and involved in the infection cycle, and are directly
implicated in generating membrane curvature13,14. Molecular
shapes of membrane proteins are highly associated with the
protein localization as well as membrane shaping and remodel-
ing15–18. Therefore, the asymmetric shape of CD9 and the
consequent curvature in the LCP crystal may explain its
accumulation into specific regions with a low curvature radius.
Furthermore, several studies have suggested clustering of
tetraspanins in biological membranes19, and such clustering
could generate local membrane curvature and thus induce
reorganization of cell membranes, as previously indicated20.
Although our hypothesis will require future elucidation, this is in
good agreement with the previous study showing that the knock-
out of the Cd9 gene results in the abnormal distribution and
shapes of microvilli in oocytes21.
MD simulation. Within the central cavity, hydrophilic residues,
such as Asn18 and Glu103, are located in the middle of the
transmembrane helices and generate a hydrophilic intramem-
branous environment (Fig. 2a), and the cavity is sealed on the
extracellular side by the association between the two extracellular
loops, SEL and LEL (Fig. 2b). To investigate the molecular
behavior of CD9, we performed a MD simulation combined with
a Markov State Model (MSM) analysis, which yielded a recon-
structed trajectory corresponding to about a 20 μs time scale
(Fig. 3a–c and Supplementary Fig. 3, Supplementary Movies 1, 2).
The simulation showed the conformational flexibilities of the SEL
and LEL, resulting in frequent transitions between the major
states, referred to as the closed, semi-open, and open
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conformations (Fig. 3a). In the closed conformation, the LEL
weakly associates with the SEL and remains beside the membrane
plane, as in the crystal structure, while in the open conformation,
the LEL adopts an up position, apart from the SEL. A similar
conformation change was also reported in the CD81 simulation,
but CD81 adopted the closed conformation only when cholesterol
is bound at the central cavity, and quickly shifted to the open
conformation without cholesterol in the simulation. In contrast,
in the current CD9 simulation, we observed spontaneous tran-
sitions between the open and closed conformations even in the
absence of cholesterol. Consistently, the critical amino acid for
the cholesterol binding (Glu219 in CD81) is not conserved in the
other tetraspanin members and is replaced with Gly210 in CD9
(Fig. 2a), while the residues lining the central cavity are highly
conserved among the tetraspanin family members (Supplemen-
tary Fig. 1). Nevertheless, we observed an electron density within
the cavity in the current closed CD9 structure, even though
cholesterol was not added during the crystallization (Fig. 2a). It is
highly possible that the monoolein molecules used in the LCP
crystallization or endogenous lipids are accommodated in the
cavity, thus suggesting the regulatory roles of lipid molecules in
the CD9 function22.
Complex structure of CD9 with EWI-2. Tetraspanin proteins
are considered to form complicated interaction networks in cells
to exert their functions, by associating and organizing other
functional proteins within these networks. To understand this
mechanism, we performed a structural analysis of CD9 in com-
plex with its major partner protein, EWI-2. EWI family proteins
belong to a immunoglobulin superfamily (IgSF), containing a

































Fig. 1 Crystal structure of human CD9. a Overall structure of human CD9, viewed from the membrane plane (left and middle) and from the extracellular
side (right). The transmembrane helices and the two extracellular loops (SEL and LEL) are labeled. Cys152-Cys181 and Cys153-Cys167 form disulfide bonds.
b Surface representation of CD9, colored according to a. c Palmitoylation of the cytoplasmic cysteine residues. Green meshes show Fo−Fc densities
contoured at 2.5 σ, indicating the palmitoylation of the cysteine residues on the cytoplasmic end of the four transmembrane helices. d Crystal packing of
CD9, showing the curvature generation by the asymmetric shape of the CD9 molecules. Pairs of CD9 protomers are aligned up and down alternatively
along the c-axis, resulting in the wavy lipid layers of the LCP crystal.
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associate with broad members of the tetraspanin proteins,
including CD9, CD81, and CD15123,24. Although their precise
functions have not been clarified, they reportedly link tetra-
spanins to the cytoskeleton and play regulatory roles in TGF-β
and integrin signaling via the tetraspanin network25–28. Con-
sistent with the previous reports24,29, CD9 forms a tight complex
with EWI-2, when the proteins are expressed together in HEK
cells (Supplementary Fig. 4a). The complex was purified in
digitonin micelles and subjected to a single particle cryo-EM
analysis, and the structure was resolved at 8.2 Å resolution with
the Fourier shell correlation (FSC) gold standard criteria (Sup-
plementary Fig. 5a, b; Supplementary Table 2). The cryo-EM map
clearly revealed the pair of the tandem Ig-like domains of the two
EWI-2 protomers extending in parallel from the detergent
micelle, indicating the dimeric architecture of EWI-2. Although
extra densities probably corresponding to the CD9 extracellular
loops were observed, the precise location of the CD9 molecules
could not be determined in the blurred density derived from the
detergent micelle (Supplementary Fig. 5a). To further improve
the alignments in the single particle analysis, an anti-CD9 Fab
fragment was attached to the complex (Supplementary Fig. 4b),
and the cryo-EM map of the Fab-CD9-EWI-2 complex was
resolved at a slightly improved resolution (7.3 Å) (Fig. 4a and

























Fig. 2 Central hydrophilic pocket and extracellular loops. a The central cavity is rendered hydrophilic by the conserved residues, Asn18 and Glu103. The
critical residue for cholesterol binding, Glu219 in CD81, is replaced by Gly210 in CD9 (Supplementary Fig. 1). The Fo−Fc map contoured at 2.5 sigma shows
an unknown density within the cavity, probably derived from the monoolein present during the lipidic cubic phase crystallization. b The central cavity is
sealed on the extracellular side by the association between the SEL and LEL. The residues involved in the interactions are shown, and the hydrogen bonding
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Fig. 3 MD simulation of CD9. a Structural comparison between the crystal structure (Cryst) and the three major conformations in the MD simulation
(Closed, Semi-open, and Open). b Time course of the contacts between the SEL and LEL in the reconstructed 100 μs trajectory. The value of 1 corresponds
to the shorter distance between the SEL and LEL, and the value of 0 corresponds to the longer distance between the SEL and LEL. For the detailed definition
of the contacts between the SEL and LEL, see Methods section. c Distribution of the contacts between the SEL and LEL in the longer reconstructed
trajectory, corresponding to the 15 ms time scale.
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separate densities for the TM helices of EWI-2 and CD9, whereas
the densities for the Fab fragments are substantially disordered in
the final refined map (Supplementary Fig. 5c). In the complex
structure, two protomers of EWI-2 form a tight dimer at the
center, accompanied by two CD9 protomers sandwiching the
EWI-2 dimer, with a 2:2 hetero-tetrameric stoichiometry.
Although the low resolution of the cryo-EM map hampered the
atomic modeling of the overall CD9-EWI-2 complex, the four Ig-
like domains and the membrane-spanning region of EWI-2 could
be roughly fitted into the density map. The arrangement of the
four transmembrane helices of CD9 is in good agreement with
that in the LCP crystal structure, whereas the LEL adopts a
slightly different conformation similar to that observed in the
semi-open conformation in the MD simulation (Supplementary
Fig. 6). The membrane-spanning helix of EWI-2 is located
proximal to the TM3–4 helices of CD9, and is likely involved in
the complex interaction (Fig. 4b). To validate the complex
interactions, we made several CD9 mutants and tested their
complex formation with EWI-2 by the fluorescence-detection
size-exclusion chromatography (FSEC) assay (Fig. 4c). We first
tested the chimeric constructs with a related tetraspanin, CD53,
which belongs to the same branch of the tetraspanin family
(Supplementary Fig. 1) but does not form a complex with EWI-2.
The exchange of the LEL region with CD53 (CD9-CD53LEL) only
moderately affected the complex formation, whereas the similar
exchange of the LEL region of CD53 with CD9 (CD53-CD9LEL)
failed to form the complex (Fig. 4c), indicating that the
interaction between CD9 and EWI-2 is essentially mediated
through the transmembrane region. Based on the amino acid
sequence comparison between CD9 and CD53 (Supplementary
Fig. 1), the single mutation of A101L, located on the outer side of
TM3, abolished the complex formation (Fig. 4c). We further
investigated the complex interaction by introducing a mutation in
the membrane-spanning region of EWI-2, which revealed that the
G587L and G595L mutations, within a Gly-zipper motif, show
decreased complex formation (Fig. 4d). As these residues are
located in the middle of the membrane-spanning region
(Supplementary Fig. 7), the complementary arrangement of the
small residues at the interface between CD9 and the EWI-2 is an
important factor for the complex formation. In addition, a
previous study showed the critical implication of the palmitoyla-
tion at the two consecutive cysteine residues of EWI-2, located on
90°
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Fig. 4 Cryo-EM structure of CD9 in complex with EWI-2. a Cryo-EM density map of the Fab-CD9-EWI-2 complex. The density for the Fab fragment was
somewhat disordered (Supplementary Fig. 6). Homology models of the Ig-like domains of EWI-2 were constructed with the PHYRE2 server80 and roughly
fitted into the density. The TM helices and the two extracellular loops (SEL and LEL) of the CD9 crystal structure are separately fitted into the density. The
density for the detergent micelle is omitted for clarity. Black panels show sections of the density, demonstrating the C2 symmetry in the TM region and the
proximal Ig-like domain. Scale bar, 100 Å. b Close-up view of the TM region. CD9 adopts a semi-open conformation with a slight rearrangement of the LEL,
as compared to the crystal structure (Supplementary Fig. 6). The residues in the EWI-2 membrane-spanning region were modeled according to the mutant
analyses in Fig. 2c, d. c, d Complex formation assays for CD9 mutants (c) and EWI-2 mutants (d). GFP-labeled CD9 and EWI-2 were co-expressed in HEK
cells, and complex formation was analyzed by FSEC. The slight peak shift toward the smaller molecular weight indicates the complex formation with
2:1 stoichiometry.
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the cytoplasmic end of the membrane-spanning region, in the
molecular association with CD8130 (Fig. 4b and Supplementary
Fig. 7).Therefore, the lipid anchoring and/or protein–lipid
interactions might also contribute to the interactions between
tetraspanins and their binding partners. It should also be noted
that, while the LEL-swapping mutant (CD9-CD53LEL) can still
form the complex with EWI-2, this mutant shows a slight peak
shift toward a smaller molecular weight in the fluorescent size-
exclusion chromatography (FSEC) analysis, probably derived
from the different stoichiometry of the complex formation
(Fig. 4c; 2:1 of EWI-2 and CD9), suggesting its weaker interaction
with EWI-2. In the current cryo-EM map, the LEL likely adopts
an open conformation, approaching the juxta-membrane Ig-like
domain of EWI-2 (Supplementary Fig. 6). Therefore, the TM
region and the LEL are both involved in the complex interaction.
In vitro fertilization assay. Tetraspanin can associate with a wide
range of proteins, enabling functional variance in different cell
types, and tetraspanin shows different levels of molecular asso-
ciation according to the binding partners19,31. We next investi-
gated the molecular role of CD9 in the fertilization process, which
is the most important function of CD9, although the precise roles
of CD9 and its binding partners in fertilization have remained
unidentified so far32,33. Consistent with the previous studies, the
eggs derived from Cd9 KO mice lacked fertilizing ability, which
could be reverted by injections of mRNAs encoding wild-type
human and mouse CD9 (Fig. 5a, b and Supplementary Fig. 8).
The crystallization construct CD9cryst also restored the sperm-
fusing ability of the Cd9 KO eggs, indicating that the partial
truncation of the LEL region and the C-terminal tail does not
affect its function in fertilization. We next investigated the
mutants of the conserved hydrophilic residues within the central
pocket (Fig. 2b), but the in vitro fertilization assay revealed the
less important roles of these residues in the fertilization, as the
N18L/E103L, E103K, and E103Q mutants only moderately
affected the CD9 function in fertilization (Fig. 5b). For further
investigation, we tested the fertilization competencies of chimeric
constructs between CD9 and the fertilization incompetent tetra-
spanin member CD53, which were used in the complex formation
assay with EWI-2. Swapping of the LEL region (CD9-CD53LEL)
diminished the competency, while the swapping of the LEL
region of CD53 with CD9 (CD53-CD9LEL) partly retained the
competency (Fig. 5b), indicating the critical role of the LEL in the
sperm-egg fusion by CD9, in contrast to the complex formation
assay with EWI-2 (Fig. 4c). A previous study reported that ala-
nine replacement of specific SFQ residues (173–175) in the
flexible region of the LEL severely defected the fertilization
competency of mouse CD934, whereas this sequence is not con-
served in human CD9 (Thr175, Phe176, and Thr177). To further
examine the importance of the this region, we constructed the
mouse and human CD9 mutants, in which the corresponding
residues are replaced with alanine (SFQ and TFT to AAA,
respectively), and tested their fertilization competencies (Fig. 5b).
Surprisingly, both mutants (mCD9(AAA) and hCD9(AAA))
could rescue the fertilization ability of the Cd9 KO oocytes,
comparable to wild type mouse and human CD9, contrary to the
previous report. Consistently, the crystallized construct that
completely lacks the corresponding region (Thr175–Lys179)
similarly rescued the fertilization ability. Overall, our result shows
dispensable role of the flexible region but an important role of the
other region of the LEL for fertilization34. Discrepancy between
the present study and the previous study about the AAA repla-
cement is presumably due to the difference in fertilization effi-
ciency and/or protein expression level, since in the previous
study, even injections of the wild type mCd9 or hCD9 mRNAs
rescued only about half of the fertilization efficiency34. It is still
noteworthy that the fertilization competency of CD53-CD9LEL is
also decreased by about half as compared to the wild-type CD9,
suggesting that the SEL and TM domains also contribute to the
CD9 function in fertilization. These results will revise conven-
tional view of the tetraspanin function that the flexible loop
region serves as the docking site for the partner proteins, thus
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Fig. 5 Sperm–egg fusion complementation assay. a Functional complementation of Cd9 KO mouse eggs by mRNA injection. The mRNA, encoding the WT
or mutants of mouse CD9, human CD9, or chimeric constructs between human CD9 and CD53, was injected into the mouse Cd9 KO eggs. The fusion of
mouse spermatozoa was visualized by the transfer of DNA dye from the eggs to the sperm nuclei. Asterisks indicate unfertilized eggs. Scale bar, 50 µm.
b Fertilization rates in the sperm–egg fusion assay. The averaged fertilization rates of repetitive experiments are shown with error bar of standard deviation.
Each dot represents one experiment. Asterisks indicate significant differences from the Cd9 KO eggs (two-tailed, unpaired Student’s t-test, *P < 0.005).
The number of experiments and eggs are indicated in Supplementary Fig. 8c and also provided as a Source Data file.
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partner proteins of CD9 in fertilization have not yet been iden-
tified, and EWI-2 in eggs is dispensable32,33. However, the current
fertilization assay revealed the critical involvement of the LEL
region, as well as the partial involvement of other regions,
showing a different hot spot of CD9 for the unidentified partner
proteins, as compared to the association with EWI-2.
Discussion
The tetraspanin proteins reportedly interact with broad members
of single-spanning membrane proteins, including integrin, a
disintegrin and metalloproteinases (ADAMs), TGF-β receptors,
and major histocompatibility complex II (MHC-II)4,19, with
different levels of molecular association19,31. The current cryo-
EM structure of the CD9-EWI-2 complex and the mutation
analysis revealed the importance of the small residues in the
transmembrane region for the complex formation between CD9
and EWI-2. Small residues, such as Gly and Ala, are often present
in the membrane-spanning regions of single membrane-spanning
proteins, and are implicated in protein dynamics, helix-helix
packing interactions, and thus in homo- and hetero-
dimerization35–38. Therefore, the molecular association observed
in the CD9-EWI-2 complex might be conserved in the complex
interactions with other binding partners, which may explain the
broad specificity for the partner proteins and the regulatory roles
of tetraspanins in their partner protein functions. The cryo-EM
structure and the mutation analysis revealed the partial involve-
ment of the LEL in the complex formation with EWI-2. The
current study shows the different dependencies of the LEL and
TM regions for the EWI-2 association and fertilization, implying
the presence of different hot spots for their partner proteins. This
multi-platform binding of CD9 could explain the different levels
of the molecular association by tetraspanins, although we cannot
exclude the possibility that CD9 has a completely different
binding site for the unidentified partner protein in fertilization.
The CD9 structures and the MD simulation further suggest other
factors affecting the molecular interactions, such as the associa-
tion between the SEL and LEL and binding of lipid molecules to
the central cavity, similar to the previous report on CD81, in
which cholesterol binding to the central cavity affected the
molecular interaction with its binding partner, CD1911 (Fig. 6a).
CD9 is abundantly expressed in mouse eggs and localized in
the microvilli tips, where they are involved in microvilli forma-
tion and sperm–egg fusion21. Tremendous studies have suggested
network formation of tetraspanin proteins in cellular membranes,
but this view is still controversial, and a recent study showed
colocalization of only a few tetraspanin molecules10. The current
study suggests a tetraspanin function that the molecular shape of
tetraspanin is directly involved in membrane curvature genera-
tion and specific localization at high curvature regions (Fig. 6b),
as proposed for other membrane proteins16. Notably, this
asymmetric shape is also preserved in the complex of CD9 and
EWI-2, indicating that CD9 can recruit other single TM-spanning
proteins into the same regions by forming heterocomplexes. In
the small vesicular exosomes, tetraspanins are the most abundant
proteins and play important roles in exosome production, protein
biogenesis, and vesicular cargo sorting, thus determining the
exosome function39. The current study suggests two possible roles
of tetraspanin in exosome function. Firstly, the clustering of tet-
raspanin molecules itself may facilitate exosome budding by
inducing membrane curvature, and secondly, the association with
tetraspanins may direct other functional proteins into the vesicles
and thus control vesicular cargo sorting, as previously
proposed13,39 (Fig. 6b). It should also be noted that, in the current
complex structure, the Ig-like domains of EWI-2 are parallel to
the membrane plane, and bent perpendicular to the TM helix,
thereby allowing additional molecular associations at the juxta-
membrane region. This suggests the possible involvements of the
EWI family proteins in indirect tetraspanin associations, by
bridging between tetraspanins and other proteins, and thus in the
vesicular cargo selection or the formation of complex protein
networks, consistent with the previous studies40,41. Overall, the
current structures of CD9 and its complex with EWI-2 will
provide a framework to understand the molecular associations
and functions of tetraspanins.
Methods
Crystallization of CD9. Cloning and protein purification were performed as in the
previous report12. The human CD9 gene (UniProt accession code: P21926) was
cloned into a modified pFastBac1 expression vector (Thermo Fischer Scientific),
which includes an N-terminal His8-tag, a GFP-tag, and a tobacco etch virus (TEV)
protease cleavage site. For the crystallization, the five extracellular-loop residues
and the three C-terminal residues of CD9 were deleted by a PCR-based method.
For mercury derivatization, a cysteine mutation was introduced by site-directed
mutagenesis.
For protein expression, these modified CD9 constructs were expressed in Sf9
cells (Thermo Fischer Scientific), using the Bac-to-Bac baculovirus expression
system. Sf9 cells cultured in Sf900II medium (Thermo Fischer Scientific) were
infected at a density of approximately 3 × 106 cells ml−1 and incubated for 48 h at
27 °C. The cells were collected by centrifugation (5000×g, 12 min), and the
following procedures were performed at 4 °C or on ice. The cells were resuspended
in 50 mM HEPES, pH 7.0, 150 mM NaCl, and protease inhibitors (1.7 µg ml−1
aprotinin, 0.6 µg ml−1 leupeptin, 0.5 µg ml−1 pepstatin, and 1 mM
phenylmethysulfonyl fluoride). The cells were disrupted by sonication, and the cell
debris was removed by centrifugation (4000×g, 10 min). The supernatant was ultra-
centrifuged (186,000×g, 1 h), and the membrane fraction was collected and













Molecular association of tetraspanin
Lipid etc.
Fig. 6 Hypothetical model of the tetraspanin function. a The molecular association of tetraspanin and its partner proteins is mediated through both the
TM and LEL regions, but its dependency is different among the partner proteins. Lipid binding to the central cavity could modulate the molecular
association by affecting the LEL conformation. b The highly asymmetric shape of the tetraspanins suggests their localization at high curvature regions and/
or clustering-induced curvature generation. Partner proteins should also be recruited and sorted to the respective regions, such as the microvilli tips and
microsomes (exosomes).
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The membrane fraction was solubilized in 10mM HEPES, pH 7.0, 150mM
NaCl, 1.5% (w/v) n-dodecyl-β-D-maltoside (DDM), and 0.3% (w/v) cholesteryl
hemisuccinate (CHS) for 1 h, and the solubilized proteins were purified by the
following three chromatography steps. The insoluble material was removed by
ultracentrifugation (186,000×g, 30 min). The supernatant was mixed with TALON
Metal Affinity Resin (Clontech), and incubated for 30min. After the incubation, the
resin was washed with seven column volumes of 10mM HEPES, pH 7.0, 150mM
NaCl, 0.1% DDM, 0.02% CHS, and 20mM imidazole. The protein sample was then
eluted with three column volumes of 10mM HEPES, pH 7.0, 150mM NaCl, 0.1%
DDM, 0.02% CHS, and 300mM imidazole. The eluted sample was mixed with His-
tagged TEV protease (purified in-house) to cleave the His8-GFP tag, and dialyzed
against 10mM HEPES, pH 7.0, 150mM NaCl, 0.1% DDM, and 0.02% CHS to
remove the imidazole. After overnight dialysis, the sample was mixed with 5 ml of
Ni-NTA Superflow resin (QIAGEN), and incubated for 10min at 4 °C, to remove
the His8-GFP tag and TEV protease. The collected flow-through fraction was then
concentrated using an Amicon Ultra filter (molecular mass cut-off 30 kDa,
Millipore), and further purified by gel filtration (Superdex 200 Increase 10/300
GL, GE Healthcare) in 10mM HEPES, pH 7.0, 150mM NaCl, 0.05% DDM, and
0.01% CHS. The peak fractions were concentrated to approximately 15 mgml−1,
using an Amicon Ultra filter (molecular mass cut-off 50 kDa, Millipore). The SDS-
PAGE analysis shows a higher molecular weight aggregation that is formed during
denaturing by SDS12. The truncated and cysteine mutants were purified by the same
procedure as described above.
The purified CD9 samples were reconstituted into the lipidic cubic phase (LCP)
by mixing with liquefied monoolein (Sigma) in a 2:3 protein to lipid ratio (w/v),
using the twin-syringe mixing method42. For the sandwich-drop crystallization,
aliquots of the protein-LCP mixture (50 nl) were dispensed onto 96-well glass
plates and overlaid with the precipitant solution (800 nL), using a Gryphon LCP
robot (Art Robbins Instruments, LLC). The best crystals were obtained in a
reservoir solution consisting of 32–38% PEG 200 and 10–50 mMMOPS, pH 6.5, or
a similar solution containing 10–50 mM Tris-HCl, pH 7.5, instead of MOPS. For
the preparation of the mercury-derivative crystals, the co-crystallization of CD9
with CH3HgCl was performed. CH3HgCl was dissolved in DMSO, and added to
the protein samples at a final concentration of 2 mM. After an incubation for 20
min on ice, the samples were crystallized by the LCP method as described above.
The best crystals were obtained in a reservoir solution similar to that used for the
native crystals. The crystals were collected within 3 weeks, using MicroMounts or
mesh grid loops (MiTeGen), and flash cooled in liquid nitrogen.
Molecular dynamics simulation. The truncated region of the LEL (Thr175-Lys179)
was modeled using Modeller43, using the CD81 structure as the template. All cysteine
residues on the TM helices (Cys9, Cys79, Cys87, and Cys219) were palmitoylated, as
in the crystal structure. All of the water molecules observed in the crystal structure
were kept. The missing hydrogen atoms were built with the program VMD44. The
protein was embedded into the phosphoryloleoylphosphatidylcholine (POPC) lipid
bilayer, using the MemProtMD pipeline45. The net charge of the simulation system
was neutralized through the addition of 150mM NaCl. The simulation system was
104 × 105 × 107 Å and contained 118,038 atoms. The molecular topologies and
parameters from the Charmm36 force field46,47 were used for the protein, lipid, and
water molecules. For the palmitoylated Cys residue, the molecular topology and
parameters were obtained from the NAMD wiki (https://www.ks.uiuc.edu/Research/
namd/wiki/index.cgi?ParameterTopologyRepository), and converted to the Gromacs
format with the charmm2gromacs-pvm.py script (http://www.gromacs.org/@api/
deki/files/185/=charmm2gromacs-pvm.py). Molecular dynamics simulations were
performed with the program Gromacs 5.1.448. First, energy minimization was per-
formed using the steepest descent, with a cut-off of 1000 kJ mol–1 nm–1 with the
position restraints to the non-hydrogen atoms in the protein with a force constant of
1000 kJmol–1. Next, random velocities were assigned according to a Maxwell dis-
tribution at a temperature of 310 K for each atom, and an equilibration run (eq1) was
performed for 100 ps in the canonical (NVT) ensemble (310 K, 104 × 105 × 107 Å
volume) with the same restraints as in the minimization step. Next, an equilibration
run (eq2) was performed for 6 ns in the isothermal–isobaric (NPT) ensemble (310 K,
1 bar) with the same restraints. Finally, the system was equilibrated in the NPT
ensemble (310 K, 1 bar) for 5 ns, with the position restraints for the C-alpha atoms of
the protein. Production runs (prod1) were performed in the NPT ensemble (310 K,
1 bar) without any position restraints. We repeated the procedure from eq1 to prod1
50 times, with different initial velocities at eq1. The simulation time of prod1 ranged
from 100 to 1000 ns, and the total sum of the simulation time was 8.42 μs.
To widely sample the conformational space, we performed clustering analyses
for these trajectories and started the MD simulations from the selected cluster
centers. Each conformation in the trajectories was featurized by the atomic
positions of its C-alpha atoms (superimposed onto the crystal structure). The
dimensions of these features were reduced to 15 with principal component analysis
(PCA), followed by k-means clustering into 2000 clusters. Subsequently, 100
clusters were randomly selected, and the structure nearest to the cluster center was
selected as the initial state of the MD simulation. The 100 ns long MD simulation
was performed for each structure, following the random initial velocity assignment
and 1 ns equilibration in the NPT ensemble. Finally, we obtained aggregated 18.42
μs trajectories, subsampled at 0.1 ns for a total of about 180,000 molecular
structures.
We performed the MSM analyses for these trajectories. Various featurizations
for the protein conformation, which describe the dynamics of the system, were
assessed, including the atomic positions of the backbone atoms, the dihedral angles
of the protein backbone, and so on. The appropriate featurization method was
selected by the 3-fold cross validation method with variational GMRQ objective
functions49, and finally we selected an RMSD based featurization: the RMSD values
for the 50 reference structures were used as the feature. The 50 reference structures
were selected from the cluster center of the k-medoid clustering over all obtained
trajectories. The RMSD values were converted by the following function:
exp½RMSD2=2σ2 with sigma= 0.5. Next, the trajectories were discretized into
500 clusters by performing the k-means clustering based on the 50-dimensional
features, followed by building the MSM with the lagtime= 20 ns (see
Supplementary Fig. 3a for the implied timescale plots of the MSM). The
hyperparameters, such as the number of clusters in the k-means clustering, were
also determined by maximizing the GMRQ score, except for the lagtime of the
MSM calculation. The contact between SEL and LEL (Fig. 3b, c) is defined as
follows: Contact ¼ 1 d=d0ð Þnð Þ= 1 d=d0ð Þð m where d is the minimum distance
between ECL1 and ECL2, d0 is the cutoff distance, and n and m are some integers.
In this paper, d0= 8.0 Å, n= 6, and m= 12 was used. For the 2-dimensional
visualization in Supplementary Fig. 3, the principal component analysis (PCA) was
performed for the 50-dimensional feature space.
Constant temperature was maintained by using V-rescaling50 with a time
constant of 0.1 ps in eq1, and a Nosé-Hoover thermostat51,52 with a time constant
of 0.5 ps in eq2 and the production runs. Pressure was controlled with semi-
isotropic coupling to a Parrinello–Rahman barostat53, with a time constant of 5.0
ps and a compressibility of 4.5 × 10−5 bar–1. The LINCS algorithm54 was used for
bond constraints. Long range electrostatic interactions were calculated with the
particle mesh Ewald method55. The simulation results were analyzed and visualized
with mdtraj56, MSMbuilder357, MSMExplorer1.1.058, scikit-learn59, and ggplot260.
Data collection and structure determination and refinement. All diffraction
datasets were collected using the micro-focused X-ray beam at SPring-8 BL32XU61.
The microcrystals in the loop were identified by a raster scan and analysis by
SHIKA62. Small wedge data, each consisting of 10–180°, were collected from single
crystals. The collected datasets were processed automatically with KAMO63. Each
dataset was indexed and integrated using XDS64, followed by a hierarchical clus-
tering analysis using the correlation coefficients of the normalized structure
amplitudes between data sets. Finally, a group of outlier-rejected data sets were
scaled and merged using XSCALE64.
The structure was determined by the single isomorphous replacement with
anomalous scattering (SIRAS) method, using the program AutoSHARP65. The
model construction and refinement were performed using the programs COOT
and PHENIX66. The data collection and refinement statistics are summarized in
Supplementary Table 1. All molecular graphics were prepared using CueMol
(http://www.cuemol.org/).
In vitro fertilization. The cDNA encoding human CD9, tagged at the N terminus
with enhanced green fluorescent protein (EGFP), was cloned between the XbaI and
XhoI sites of the pCAGGS vector67. The mutations were introduced by a PCR-
based method. T7 promoter-tagged cDNAs were amplified by PCR with the pri-
mers (5′-GGGTAATACGACTCACTATAGGGGCAACGTGCTGGTTGTTGT
GC-3′ and 5′-AGCCAGAAGTCAGATGCTCAAGGGGCTTC-3′) and high fidelity
Taq polymerase, using the pCAGGS vectors as templates. RNA synthesis, poly-A
tail addition, and further preparation for egg injection were performed as pre-
viously described, using a mMESSAGE mMACHINE T7 kit (Ambion) and a Poly
(A) Tailing kit (Ambion) according to the manufacturer’s instructions.
Gene complementation experiments using Cd9 deficient eggs were performed
basically according to the previous study68. Immature, germinal vesicle eggs were
collected from the ovaries of wild-type B6D2F1 or Cd9 KO female mice
(10–20 weeks old), 46 h after the injection of anti-inhibin antibody solution
(CARD HyperOva, Kyudo). Antral follicles were suspended in FHM medium
supplemented with 250 μM dibutyryl-cyclic AMP (dbcAMP), and punctured with
26 G needles (Sigma). After dissociating the cumulus cells by pipetting, the eggs
were transferred to the medium supplemented with 250 μM dbcAMP and 5 μg ml−1
cytochalasin B (Sigma), and then the injections of mRNAs (100 ng µl−1) into the
eggs were performed using a piezo-micromanipulator with a glass capillary needle.
The eggs were washed three times, and then cultured in TYH medium containing
10% fetal bovine serum (Biowest) for in vitro maturation. After 14 h, the zona were
removed from the MII eggs, using a micromanipulator69. Pre-loading of Hoechst
33342 into the denuded eggs was performed, as previously described70, and after
three washes with fresh TYH medium, the eggs were subjected to confocal image
acquisition with the low-invasive imaging system71, and only the eggs with adequate
EGFP fluorescence intensities on the oolemma were used for the fusion assay. In
one experiment, considering the failure of superovulation, 2–4 Cd9 KO female mice
were assigned to an experimental group and 2 WT mice were assigned to a
control group.
Hoechst 33342 pre-loaded eggs were inseminated with 2 × 105 cells ml−1
B6D2F1 capacitated sperm, for 30 min. After a quick wash in kSOM medium, the
eggs were subjected to confocal imaging. Confocal images were acquired as
described68. Experiments were repeated at least three times for each batch. Total
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numbers of inseminated eggs per batch (28–150) are indicated in Supplementary
Fig. 8c.
Protein expression and purification for cryo-EM. The human wild type CD9
gene was cloned into the pEG BacMam vector72, with an N-terminal His8-tag, a
GFP-tag, and a tobacco etch virus (TEV) protease cleavage site. The human EWI-2
(UniProt accession: Q969P0) wild type genes were cloned from human brain
complementary DNA (ZYAGEN) into the pEG BacMam vector, with a C-terminal
Flag epitope (DYKDDDDK)-tag.
CD9 and EWI-2 were co-expressed in HEK293S GnTI- (N-acetylglucosaminyl-
transferase I-negative) cells (American Type Culture Collection, catalog no. CRL-
3022), using the BacMam expression system72. For protein expression, HEK293S
GnTI- cells cultured in FreeStyle medium (Thermo Fischer Scientific) were infected
at a density of approximately 3 × 106 cells ml−1 and incubated at 37 °C. After 16 h,
sodium butyrate was added to the cells, which were further incubated for 48 h at 30
°C. The membrane fractions were collected by the same procedure as described
above, and solubilized in 10 mM HEPES, pH 7.0, 150 mM NaCl, and 1% digitonin
(Calbiochem) for 1 h at 4 °C. Insoluble materials were removed by
ultracentrifugation (186,000×g, 30 min). The supernatant was mixed with ANTI-
FLAG M2 Affinity gel (Sigma), and incubated for 1 h. After the incubation, the
resin was washed with ten column volumes of 10 mM HEPES, pH 7.0, 150 mM
NaCl, and 0.1% digitonin. The protein sample was then eluted with three column
volumes of 10 mM HEPES, pH 7.0, 150 mM NaCl, 0.1% digitonin, and Flag peptide
(0.1 mgml−1). The eluted sample was mixed with CNBr-Activated Sepharose 4
Fast Flow beads (GE Healthcare) coupled with an anti-GFP nanobody (GFP
enhancer)73, and incubated for 1 h at 4 °C. The beads were washed with ten column
volumes of 10 mM HEPES, pH 7.0, 150 mM NaCl, and 0.1% digitonin, and further
incubated overnight with TEV protease to cleave the His8-GFP tag. The collected
flow-through fraction was then concentrated with an Amicon Ultra filter
(molecular mass cut-off 50 kDa, Millipore), and further purified by gel filtration
(Superose 6 Increase 10/300 GL column, GE Healthcare) in 10 mM HEPES, pH 7.0,
150 mM NaCl, and 0.1% digitonin.
The mouse-derived IgG antibody Fab fragment that specifically binds to human
CD9 was prepared according to the previous method74,75. To prepare the complex
with Fab fragments, the concentrated sample was mixed with the Fab fragments at
a 1:0.4 weight ratio and incubated on ice for 1 h before the gel filtration. The peak
fractions of these proteins were collected and concentrated to 5 mgml−1. A 3 µl
portion of the concentrated sample was applied to a glow-discharged Quantifoil
R1.2/1.3 Cu/Rh 300 mesh grid (Quantifoil), blotted using a Vitrobot Mark IV (FEI)
under 6 °C and 100% humidity conditions, and then frozen in liquid ethane.
EM image acquisition and data processing. The grid images of the CD9-EWI-2
and Fab-CD9-EWI-2 complexes were obtained with a Talos Arctica transmission
electron microscope (FEI) operated at 200 kV, and recorded by a K2 Summit direct
electron detector (Gatan) with a physical pixel size of 1.352 Å. The dataset was
acquired with the EPU software (FEI). Each image was dose fractionated to 40
frames at a dose rate of 6–8 e− pixel−1 per second, to accumulate a total dose of
~50 e−Å−2. In total, 2360 and 1398 movies were collected for the Fab-CD9-EWI-2
CD9-EWI-2 complexes, respectively. The movie frames were aligned in 5 × 5
patches and dose weighted in MotionCor276. Defocus parameters were estimated
by CTFFIND 4.177. For the analysis of the Fab-attached complex, a total of 542,954
particles were picked up by Laplacian-of-Gaussian based auto-picking imple-
mented in REILON 3.0 was performed, and extracted in 4.23 Å pixel−1. These
particles were subjected to two-dimensional classification with the Ignore CTFs
until first peak option, and selected classes were further classified in 3D in RELION
3.078,79. Subsequently, 124,701 good particles were selected, re-extracted in original
pixel size (1.352 Å pixel−1), and subjected to Bayesian polishing implemented in
RELION 3.0 and 3D auto-refine with the mask excluding the Fab densities.
Postprocessing yielded a 7.3 Å resolution map, based on the gold-standard (FSC=
0.143) criteria. The analysis of the CD9-EWI-2 complex was performed in a similar
manner but without Bayesian polishing, because it did not improve the density.
Briefly, a total of 276,879 particles was initially extracted and 82,071 particles were
used for final reconstruction, with the pixel size of 2.82 Å pixel−1. The overall gold-
standard resolution was 8.2 Å.
FSEC assay. The interaction between CD9 and EWI-2 was analyzed by
fluorescence-detection size-exclusion chromatography (FSEC). HEK293T adhesion
cells (0.4 × 106 ml−1) were cultured in 6-well plates (2000 µl per well) with DMEM
containing 10% FBS for 1 day, and transfected with 2 µg of the CD9-encoding pEG
expression plasmid with a GFP-tag and 2 µg of the EWI-2-encoding pEG
expression plasmid with a FLAG-tag, using 5 µl of Lipofectamine 2000 transfection
reagent (Thermo Fisher), according to the manufacturer’s instructions. The cells
were collected 2 days after transfection by centrifugation (9100×g, 1 min, 4 °C), and
solubilized by adding 200 µl of buffer containing 50 mM HEPES, pH 7.0, 150 mM
NaCl, 1% digitonin (Calbiochem), and protease inhibitor cocktail (Roche) for 1 h at
4 °C. After removing the insoluble material by ultracentrifugation (86,000×g, 20
min, 4 °C), 150 µl portions of the supernatant were applied to a Superose 6 Increase
10/300 GL column (GE Healthcare), pre-equilibrated with buffer containing 10
mM HEPES, pH 7.0, 150 mM NaCl, and 0.1% digitonin, and the GFP fluorescence
was monitored using an RF20Axs fluorescence detector (Shimadzu). The expres-
sion of the EWI-2 mutants was analyzed by western blotting. The whole cell
extracts of the transfected cells were fractionated by SDS-PAGE under non-
reducing conditions and transferred to a polyvinylidene difluoride membrane.
After an incubation with Signal Enhancer HIKARI (nacalai tesque) for 1 h, the
membrane was incubated with anti-FLAG M2 monoclonal IgG (SIGMA, F3165)
(1:3000) for 30 min and, after washing, further incubated with horseradish
peroxidase-conjugated anti-mouse polyclonal IgG (Bio-Rad, STAR207P) (1:3000)
for 30 min. Blots were washed with Signal Enhancer HIKARI three times and
developed with Chemi-Lumi One (nacalai tesque) according to the manufacturer’s
protocols.
Animal experiments. Neither randomization nor blinding was used for the
selection of animals. All animal experiments were approved by the Animal Care
and Use Committee of the Research Institute for Microbial Diseases, Osaka Uni-
versity (Osaka, Japan).
Animals. The Cd9-disrupted mice (Cd9 KO) were a generous gift from Dr. E.
Mekada7. Hybrid B6D2F1 male and female mice were purchased from Japan SLC.
All animals were >8 weeks old when used.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this Article is available as a
Supplementary Information file. The source data underlying Fig. 5b and Supplementary
Fig 7a are provided as a Source Data file. The atomic coordinate for the CD9 crystal has
been deposited in the Protein Data Bank, with the accession codes PDB 6K4J. X-ray
diffraction images are available at Zenodo data repository (https://doi.org/10.5281/
zenodo.3716303). Cryo-EM density maps of the complex structures have been deposited
in the Electron Microscopy Data Bank, with the accession codes EMD-30026 and EMD-
30027 for CD9-EWI-2 and CD9-Fab-EWI-2, respectively.
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